biospace med (France) - Dec 2007

biospace med, an orthopaedic imaging company, has announced a €12m second round of investment led by NBGI Ventures and Crédit Agricole Private Equity. Original investors Edmond de Rothschild Investment Partners and UFG Private Equity which invested €7.5m in 2005, have also joined the new round of investment. The deal was arranged by Aelios Finance and took less than three months to complete.

Company

biospace med was founded in 1999 by Georges Charpak together with medical engineers, radiologists and orthopaedic surgeons. The investment will advance the deployment of EOS, a device which can capture 3D body images in a single scan with 10 times less radiation than regular x-ray, in order to take a leading position in the billion dollar orthopedic imaging market. EOS uses a patented particle detector for which Georges Charpak won the 1992 Nobel Prize for Physics. biospace employs around 45 people and has offices in Atlanta and Paris.

People

Marie Meynadier is the CEO of biospace med. Christian Sarwa worked on the deal for NBGI Ventures, while Olivier Denigot was in charge for UFG PE and Alexia Perouse for Crédit Agricole Private Equity.

Advisers

Management - Aelios Finance, (Corporate Finance)

Sourced from: France unquote" 88 (Feb 2008)

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Early-stage
• Healthcare
• France